Edward P Bowman

Title: Edward P Bowman: Innovator in Immunotherapy

Introduction

Edward P Bowman is a prominent inventor based in San Carlos, CA (US). He has made significant contributions to the field of immunotherapy, holding a total of 14 patents. His work focuses on developing innovative solutions for cancer treatment and immune response enhancement.

Latest Patents

Bowman's latest patents include groundbreaking inventions such as human interleukin-2 conjugates that are biased for the interleukin-2 receptor beta GAMMAc dimer. These conjugates are conjugated to a nonpeptidic, water-soluble polymer. Additionally, he has developed interleukin-2 (IL-2) conjugates that comprise amino acid substitutions, which enhance binding to the IL-2 receptor βγ dimer over the IL-2 receptor αβγ trimer. These IL-2 conjugates are particularly useful for the treatment and prevention of cell proliferation and cancer in patients. Another notable invention involves PD1 and/or LAG3 binders, which are engineered molecules that bind to PD1 and LAG3, potentially increasing immune response and treating cancer or infectious diseases.

Career Highlights

Throughout his career, Edward P Bowman has worked with esteemed companies such as Schering Corporation and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to refine his expertise in immunotherapy and contribute to significant advancements in the field.

Collaborations

Bowman has collaborated with notable colleagues, including Maribel Beaumont and Marie-Ange Buyse. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Edward P Bowman is a distinguished inventor whose work in immunotherapy has the potential to transform cancer treatment and enhance immune responses. His numerous patents reflect his commitment to advancing medical science and improving patient outcomes.